Hospital News and Research

RSS

Education and cardiac defibrillators can boost survival rates

More widespread availability of defibrillators and education of the general public could boost survival rates fourfold amongst athletes suffering cardiac arrest, a study has found. In less than half of cases, a bystander initiated cardiopulmonary reanimation. This is crucial as survival at hospital admission is 4 times higher when CPR is attempted and 10 times greater when an electric shock is delivered.

2 Sep 2009

Current European practice and routines associated with the implantation of a CRT device described

The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology.

2 Sep 2009

Grossman Burn Center will be relocating to West Hills Hospital & Medical Center in 2010

Grossman Burn Center, one of the nation's leading burn care facilities, will be relocating from Sherman Oaks Hospital to West Hills Hospital & Medical Center in the first quarter of 2010. The joint announcement was made on Monday, August 31, 2009.

2 Sep 2009

Primary angioplasty procedures vary in European countries

Primary angioplasty (with stent implantation) is the most effective therapy for acute myocardial infarction (AMI), but it is not available to many patients, even though most European countries have sufficient resources (ie, catheterisation laboratories) for its wider use.

2 Sep 2009

Telemedical supervision for chronic heart failure patients reduces hospital expenses

The current data confirms previous health economic evaluations: If patients with chronic heart failure are receive telemedical supervision, this means that they will require less and shorter hospital care. In this study hospital expenses dropped by around 70 percent in a year.

2 Sep 2009

PROTECT clinical study aimed at the assessment of rolofylline effects

Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.

2 Sep 2009

Expanding health centers to reach more patients will result in huge health care savings

Expanding health centers to reach an additional 20 million patients as part of national health reform would result in overall health care savings of $212 billion over the ten-year period 2010 to 2019, including federal Medicaid savings of $59 billion.

2 Sep 2009

CDEX ValiMed medication safety system selected by Brigham and Women's Hospital

CDEX Inc. announces that Brigham and Women's Hospital (Boston, MA) has selected the CDEX ValiMed™ Medication Safety System as part of its Medication Safety Program.

2 Sep 2009

Rapid progression of multiple sclerosis linked to smoking

Patients with multiple sclerosis who smoke appear to experience a more rapid progression of their disease, according to a report in the July issue of Archives of Neurology, one of the JAMA/Archives journals.

2 Sep 2009

New therapy delays the progression of heart failure

A therapy called cardiac resynchronization can significantly delay the progression of heart failure, according to a major international study published in the New England Journal of Medicine.

2 Sep 2009

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

Misonix, Inc., (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the second expansion of its direct sales channel for the United States, which was first disclosed in June 2008.

2 Sep 2009

New ARRA-funded research on white blood cell functioning

The American Recovery and Reinvestment Act (ARRA) has provided funding for new research to learn more about how white blood cells work. Jonathan Reichner, PhD, of the department of surgery at Rhode Island Hospital has received a grant from the National Institutes of Health with funding through the American Recovery and Reinvestment Act. Reichner's hope is that the research will lead to new immune-enhancing therapies, with potential implications for improvements in both cancer treatment and controlling inflammation accompanying injury and infection.

2 Sep 2009

$Prolonged surgery should be avoided in trauma patients with multiple fractures$

Prolonged surgery should be avoided in trauma patients with multiple fractures

Trauma patients who sustain multiple fractures are often in serious condition when they arrive at the emergency department. A review article published in the September 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) explains that trauma patients who have several orthopaedic injuries and are considered to be in unstable condition should only have a few hours of surgery when first arriving at the hospital. This principle is known as 'damage control'.

2 Sep 2009

New method found for the diagnosis of cartilage disease

In its quest to find new strategies to treat osteoarthritis and other diseases, a Boston University-led research team has reported finding a new computer tomography contrast agent for visualizing the special distributions of glycosaminoglycans (GAGs) - the anionic sugars that account for the strength of joint cartilage.

2 Sep 2009

GE Healthcare to develop wireless medical monitoring systems for patient care

In what would represent an important step forward in revolutionizing the way patients are monitored in the future, GE announced an initiative aimed to develop wireless medical monitoring systems, or body sensor networks (BSN), which would replace the traditional tangle of bedside cables used to capture a patient’s vital signs. GE’s vision for the systems would enable wireless monitoring from anywhere in the hospital—or even remotely from home.

2 Sep 2009

Eating Recovery Center releases white paper on referral practices

Eating Recovery Center (www.eatingrecoverycenter.com), a behavioral hospital focused on comprehensive and sustainable treatment of eating disorders, today released a white paper, "Eating Recovery Center's Report on Referral Practices: Recent Research Reveals Trends in the Process of Referrals for Eating Disordered Patients."

2 Sep 2009

PLATO study reveals that ticagrelor reduces the rate of cardiovascular events

The presentation of the PLATO (A Study of Platelet Inhibition and Patient Outcomes), showed that ticagrelor (Brilinta) reduced the rate of cardiovascular (CV) events (CV death, myocardial infarction or stroke) from 11.7% to 9.8% compared clopidogrel (Plavix®) XX% (p<0.001, RRR = 16%), without an increase in major bleeding.

2 Sep 2009

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.

2 Sep 2009

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

In a major international trial, researchers from McMaster University in Canada, found that the hypertension drug irbesartan reduced the risk of heart failure complications and the combination of stroke, other embolic events and transient ischemic events, also known as ministrokes, in patients with atrial fibrillation.

2 Sep 2009

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.

2 Sep 2009

Hospital News and Research

Education and cardiac defibrillators can boost survival rates

Current European practice and routines associated with the implantation of a CRT device described

Grossman Burn Center will be relocating to West Hills Hospital & Medical Center in 2010

Primary angioplasty procedures vary in European countries

Telemedical supervision for chronic heart failure patients reduces hospital expenses

PROTECT clinical study aimed at the assessment of rolofylline effects

Expanding health centers to reach more patients will result in huge health care savings

CDEX ValiMed medication safety system selected by Brigham and Women's Hospital

Rapid progression of multiple sclerosis linked to smoking

New therapy delays the progression of heart failure

Misonix commences direct to hospital sales of its SonaStar Ultrasonic Surgical Aspirator in the US

New ARRA-funded research on white blood cell functioning

Prolonged surgery should be avoided in trauma patients with multiple fractures

New method found for the diagnosis of cartilage disease

GE Healthcare to develop wireless medical monitoring systems for patient care

Eating Recovery Center releases white paper on referral practices

PLATO study reveals that ticagrelor reduces the rate of cardiovascular events

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News